Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence.
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence.
复制标题
DOI：
10.1007/s11892-023-01515-1
复制
发表时间：
2023-08
影响因子：
4.2
通讯作者：
Yeh, Hsin-Chieh
中科院分区：
文献类型：
--
作者：
Wong, Rachel;Lam, Emily;Bramante, Carolyn T. T.;Johnson, Steven G. G.;Reusch, Jane;Wilkins, Kenneth J. J.;Yeh, Hsin-Chieh
多项研究报告了SARS-CoV-2感染后糖尿病的发病率增加。考虑到糖尿病的潜在全球负担增加，了解SARS-CoV-2在糖尿病流行病学中的作用非常重要。我们的目的是审查与COVID-19感染后发生糖尿病风险有关的证据。与未感染SARS-CoV-2的患者相比，发生糖尿病的风险增加了约60%。与非COVID-19呼吸道感染相比，风险也增加了，这表明SARS-CoV-2介导的机制，而不是呼吸道疾病后的一般发病率。关于SARS-CoV-2感染与T1 D之间的联系，证据好坏参半。SARS-CoV-2感染与T2 D风险升高相关，但尚不清楚糖尿病事件是否随时间持续或随时间推移严重程度不同。SARS-CoV-2感染与糖尿病发病风险增加有关。未来的研究应评估疫苗接种、病毒变异以及影响风险的患者和治疗相关因素。
Multiple studies report an increased incidence of diabetes following SARS-CoV-2 infection. Given the potential increased global burden of diabetes, understanding the effect of SARS-CoV-2 in the epidemiology of diabetes is important. Our aim was to review the evidence pertaining to the risk of incident diabetes after COVID-19 infection. Incident diabetes risk increased by approximately 60% compared to patients without SARS-CoV-2 infection. Risk also increased compared to non-COVID-19 respiratory infections, suggesting SARS-CoV-2-mediated mechanisms rather than general morbidity after respiratory illness. Evidence is mixed regarding the association between SARS-CoV-2 infection and T1D. SARS-CoV-2 infection is associated with an elevated risk of T2D, but it is unclear whether the incident diabetes is persistent over time or differs in severity over time. SARS-CoV-2 infection is associated with an increased risk of incident diabetes. Future studies should evaluate vaccination, viral variant, and patient- and treatment-related factors that influence risk.
登录
查看更多内容
影响因子：
29
作者：
Coate KC;Cha J;Shrestha S;Wang W;Gonçalves LM;Almaça J;Kapp ME;Fasolino M;Morgan A;Dai C;Saunders DC;Bottino R;Aramandla R;Jenkins R;Stein R;Kaestner KH;Vahedi G;HPAP Consortium;Brissova M;Powers AC
通讯作者：
Powers AC
影响因子：
1
作者：
Genc, S.;Evren, B.;Sahin, I.
通讯作者：
Sahin, I.
影响因子：
64.8
作者：
Al-Aly, Ziyad;Xie, Yan;Bowe, Benjamin
通讯作者：
Bowe, Benjamin
DOI：
10.1016/j.eprac.2021.04.004
发表时间：
2021-08
期刊：
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
影响因子：
--
作者：
Chen M;Zhu B;Chen D;Hu X;Xu X;Shen WJ;Hu C;Li J;Qu S
通讯作者：
Qu S
影响因子：
9.8
作者：
Lai, Honghao;Yang, Manli;Sun, Mingyao;Pan, Bei;Wang, Quan;Wang, Jing;Tian, Jinhui;Ding, Guowu;Yang, Kehu;Song, Xuping;Ge, Long
通讯作者：
Ge, Long